Lesinurad, a Selective Uric Acid Reabsorption Inhibitor, in Combination With Febuxostat in Patients With Tophaceous Gout: Findings of a Phase III Clinical Trial.
about
Lesinurad monotherapy in gout patients intolerant to a xanthine oxidase inhibitor: a 6 month phase 3 clinical trial and extension study.Guideline development for the management of gout: role of combination therapy with a focus on lesinurad.Lesinurad for the treatment of hyperuricaemia in people with gout.Treatment of gout: where are we now?Pharmacodynamic and pharmacokinetic effects and safety of verinurad in combination with allopurinol in adults with gout: a phase IIa, open-label study.Physiology of Hyperuricemia and Urate-Lowering Treatments.Pharmacodynamic and pharmacokinetic effects and safety of verinurad in combination with febuxostat in adults with gout: a phase IIa, open-label study.Pharmacokinetics, pharmacodynamics, and tolerability of verinurad, a selective uric acid reabsorption inhibitor, in healthy Japanese and non-Asian male subjects.Impact of pegloticase on patient outcomes in refractory gout: current perspectivesUrate transporter inhibitor lesinurad is a selective peroxisome proliferator-activated receptor gamma modulator (sPPARγM) in vitro
P2860
Q42696818-43E3C45C-22F8-45A3-9785-C77B2AE4E510Q47104482-75C3AAE8-E303-4B86-B191-90AEAFBF85E1Q47657420-138E4DDC-8345-4DA3-9D67-E92E929DFA78Q49616087-B3D8910E-3E55-4371-87FD-1FEBD319C708Q53837944-1A1F3935-2EC0-4E91-8F68-F6BE39EDA9F0Q55163806-C8750A76-DB44-4135-ADB6-9D2075E02170Q55286574-18EC1EAC-3FEE-4DAF-BECC-AB39DF9ACE0FQ55334448-3F6BFC8E-93AB-46F4-B0D3-80F01B440FE0Q58698860-E673EE75-AA16-4B95-A6D0-A7EB343A1D2BQ58756051-68980EF4-62C7-4383-AFCE-D484C0947BBC
P2860
Lesinurad, a Selective Uric Acid Reabsorption Inhibitor, in Combination With Febuxostat in Patients With Tophaceous Gout: Findings of a Phase III Clinical Trial.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Lesinurad, a Selective Uric Ac ...... of a Phase III Clinical Trial.
@en
type
label
Lesinurad, a Selective Uric Ac ...... of a Phase III Clinical Trial.
@en
prefLabel
Lesinurad, a Selective Uric Ac ...... of a Phase III Clinical Trial.
@en
P2093
P2860
P356
P1476
Lesinurad, a Selective Uric Ac ...... of a Phase III Clinical Trial.
@en
P2093
Chris Storgard
Dinesh Khanna
Graeme Jones
Jeff Kopicko
Maple Fung
Nihar Bhakta
Robert Terkeltaub
Scott Adler
Scott Baumgartner
P2860
P304
P356
10.1002/ART.40159
P577
2017-06-09T00:00:00Z